Author

Chris S. J. Probert 1

1 University of Liverpool, Liverpool, United Kingdom

EARLY RELAPSE OF ULCERATIVE COLITIS AFTER DISCONTINUATION OF TREATMENT IN PATIENTS RESPONDING TO GOLIMUMAB 

P. John Hamlin, Shaji Sebastian, Peter Irving, Daniel R. Gaya, Colin Wheeler, Anita Rose, Gillian Gillespie, Chris S. J. Probert

GO-COLITIS 6-WEEK INDUCTION PATIENT-REPORTED OUTCOMES OF PARTIAL MAYO SCORE RESULTS

Shaji Sebastian, Chris S. J. Probert, Daniel R. Gaya, Peter John Hamlin, Peter Irving, Gillian Gillespie, Helen Tate, Colin Wheeler

GO-COLITIS: EFFICACY AND QUALITY OF LIFE DURING GOLIMUMAB MAINTENANCE IN UK PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Chris S. J. Probert

GO-COLITIS: EFFICACY AND QUALITY OF LIFE DURING GOLIMUMAB MAINTENANCE IN UK PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Daniel R. Gaya, Peter Irving, Shaji Sebastian, P. John Hamlin, Colin Wheeler, Anita Rose, Gillian Gillespie, Chris S. J. Probert

IMPACT OF NF-?B SUBUNIT DELETION ON THE SMALL INTESTINAL EPITHELIAL TRANSCRIPTOME FOLLOWING LIPOPOLYSACCHARIDE TREATMENT OF C57BL/6 MICE

Michael David Burkitt, Jonathan M Williams, Yvette Merga, Nigel Dyer, Jorge Caamano, Philip Rosenstiel, Barry J. Campbell, David Mark Pritchard, Chris S. J. Probert

LOW FODMAP DIET & PREBIOTIC GALACTOOLIGOSACCHARIDES IMPROVE IRRITABLE BOWEL SYNDROME SYMPTOMS AND RESPONSE TO LOW FODMAP DIET IS PREDICTED BY URINE METABOLOME, STOOL SHORT-CHAIN FATTY ACIDS AND VOLATILE ORGANIC COMPOUNDS: A RANDOMISED CONTROLLED TRIAL

Bridgette Wilson, Rachael Hough, Tokuwa Kanno, Megan Rossi, Gareth Parkes, Qasim Aziz, Simon H. Anderson, Peter Irving, Miranda Lomer, A James Mason, Chris S. J. Probert, Kevin Whelan

ROLE OF BASELINE INFLAMMATORY MARKERS IN PREDICTING EARLY RESPONSE AND REMISSION TO VEDOLIZUMAB

Thomas Skouras, Chris S. J. Probert, Paul Collins, Ashley Bond, Gareth Fisher, Belle Gregg, Daniel Storey, Hayley Stanley, Sree Subramanian

Item 1 - 7 / 23
1
2 3